“Interesting that it's not posted--LL mentioned
Post# of 148190
IMO, NP should combine the published clinical findings of leronlimab with the published laboratory findings from Dr. BP for some type of presentation. The two together provide peer reviewed, clinically and statistically significant data to support leronlimab’s role in the S/C population. What else do you need to drive the interest up for the S/C trial?